Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid Receptors in Myocardial Injury: A Brother Born to Rival
Xinru Tang, Zheng Liu, Xiaoqing Li, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6886-6886
Open Access | Times Cited: 15

Showing 15 citing articles:

Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 22
CB1 Cannabinoid Receptor Signaling and Biased Signaling
Luciana M. Leo, Mary E. Abood
Molecules (2021) Vol. 26, Iss. 17, pp. 5413-5413
Open Access | Times Cited: 74
Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery
Lei Tian, Taotao Qiang, Shanglong Liu, et al.
Pharmacology & Therapeutics (2025), pp. 108795-108795
Closed Access | Times Cited: 1
Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries
Pan Gao, Mengying Cao, Xueli Jiang, et al.
Circulation (2022) Vol. 147, Iss. 2, pp. 158-174
Open Access | Times Cited: 28
Antipsychotics cardiotoxicity: What's known and what's next
Xiaoqing Li, Xinru Tang, Liliang Li
World Journal of Psychiatry (2021) Vol. 11, Iss. 10, pp. 736-753
Open Access | Times Cited: 33
CB1R-stabilized NLRP3 inflammasome drives antipsychotics cardiotoxicity
Liliang Li, Pan Gao, Xinru Tang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 23
Analysis of the therapeutic basis of cannabis and its application in medicine
María Ilusión Solís Sánchez, Shirley Carolina Flores Guillen, Matías Josué Luna Mena, et al.
Salud Ciencia y Tecnología (2024) Vol. 4, pp. 937-937
Open Access | Times Cited: 3
Macrophage Heterogeneity and Its Impact on Myocardial Ischemia-Reperfusion Injury: An Integrative Review
Shuwan Xu, Cong Xu, Jiahua Xu, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5971-5987
Open Access | Times Cited: 8
Activation of cannabinoid receptor 2 attenuates Angiotensin II-induced atrial fibrillation via a potential NOX/CaMKII mechanism
Dengyue Xu, Chennian Xu, Xiaodong Xue, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective
Giuseppe Felice Mangiatordi, Maria Maddalena Cavalluzzi, Pietro Delre, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 469-469
Open Access | Times Cited: 4
The Endocannabinoid System as a Target for Neuroprotection/Neuroregeneration in Perinatal Hypoxic–Ischemic Brain Injury
Andrea Duranti, Gorane Beldarrain, Antonia Álvarez, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 28-28
Open Access | Times Cited: 7
Why Multitarget Vasodilatory (Endo)cannabinoids Are Not Effective as Antihypertensive Compounds after Chronic Administration: Comparison of Their Effects on Systemic and Pulmonary Hypertension
Patryk Remiszewski, Barbara Malinowska
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1119-1119
Open Access | Times Cited: 6
Characterization of URB Series Synthetic Cannabinoids by HRMS and UHPLC–MS/MS
Marco Agostini, Donata Favretto, Caterina Renzoni, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 201-201
Open Access | Times Cited: 3
Re-evaluation of the cardioprotective effects of cannabinoids against ischemia-reperfusion injury according to the IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria
Anna Pędzińska‐Betiuk, Eberhard Schlicker, Jolanta Weresa, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Cardiotoxicity of current antipsychotics: Newer antipsychotics or adjunct therapy?
Zheng Liu, Mo-Lin Zhang, Xinru Tang, et al.
World Journal of Psychiatry (2022) Vol. 12, Iss. 8, pp. 1108-1111
Open Access | Times Cited: 1
Page 1

Scroll to top